FDA approves new treatment for advanced prostate cancer
WEBJul 12, 2023 · In June, the FDA approved a new treatment for the most advanced type of prostate cancer. Patients who have this condition, which is called metastatic castration-resistant prostate cancer (mCRPC), have few therapeutic options, so the approval helps to fill an urgent need.
FDA Approves Promising Therapy for Advanced Prostate Cancer ...
WEBMar 23, 2022 · Prostate cancer treatment took a major step forward today as the U.S. Food and Drug Administration approved a new therapy that zeros in on cancer cells to destroy them. The treatment, called 177 Lu-PSMA-617, uses a molecule that selectively seeks out and attaches to a specific protein on the cancer cell surface called PSMA (prostate-specific ...
Xtandi Approved for High-Risk Prostate Cancer - NCI
WEBJan 5, 2024 · Enzalutamide (Xtandi) can now be used alone or combined with leuprolide to treat some people with prostate cancer who have had a biochemical recurrence.
A Promising New Therapy for Advanced Prostate Cancer
WEBJun 3, 2021 · Prostate cancer treatment stands on the brink of a major advance with the development of a new treatment that zeros in on cancer cells to destroy them. The therapy, called 177 Lu-PSMA-617, uses a molecule that selectively seeks out and attaches to a specific protein on the cancer cell surface.
Prostate Cancer News - ScienceDaily
WEB6 days ago · Learn the symptoms of prostate cancer. Read current medical research on new treatment options, vaccines, surgery and prevention.
Breaking News: FDA Approves Enzalutamide as a Treatment ...
WEBNov 17, 2023 · Enzalutamide is a newer form of treatment for prostate cancer called an androgen receptor pathway inhibitor. It is an oral pill taken daily. It was already approved and in use to treat advanced prostate cancer.
New radiation therapy for prostate cancer reduces deaths ...
WEBJun 3, 2021 · The trial was investigating a new, potentially groundbreaking type of treatment for prostate cancer, a therapy that specifically targets a protein on the cancer cells.
FDA Approves Relugolix for Advanced Prostate Cancer
WEBJan 26, 2021 · A new drug approved by the Food and Drug Administration (FDA) is expected to immediately affect the treatment of some men with prostate cancer. In a large clinical trial, the drug, relugolix (Orgovyx), was shown to be more effective at reducing testosterone levels in men with advanced prostate …
Research team identifies a new way to treat prostate cancer
WEBMay 22, 2024 · Using a drug that inhibits Stat5, Dr. Nevalainen measured androgen receptor levels and prostate cancer growth in cell cultures and human tumors in vitro and grafted into mice.
Talazoparib Combo Approved for Metastatic Prostate Cancer
WEBAug 4, 2023 · FDA based the approval of enzalutamide (Xtandi) plus talazoparib (Talzenna) on a large clinical trial that showed the combination was more effective than enzalutamide alone in treating men with metastatic castration-resistant prostate cancer.
- Some results have been removed